Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1218

BillFederalSenateIn Committee
To require that the retail list price for certain prescription drugs and biological products may not exceed the average retail list price for the drug or biological product among certain nations.
About This Bill
Committee
Latest Action · April 19, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
April 19, 2023
Cosponsors (0)
None
View PDF ↗
SummaryFull TextCommentsAnnotations

Full Text

The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:

A plain-language summary is on the Summary tab — you can highlight and annotate it there.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.